Your browser doesn't support javascript.
loading
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.
Schito, Marco; Migliori, Giovanni Battista; Fletcher, Helen A; McNerney, Ruth; Centis, Rosella; D'Ambrosio, Lia; Bates, Matthew; Kibiki, Gibson; Kapata, Nathan; Corrah, Tumena; Bomanji, Jamshed; Vilaplana, Cris; Johnson, Daniel; Mwaba, Peter; Maeurer, Markus; Zumla, Alimuddin.
Afiliação
  • Schito M; Critical Path to TB Drug Regimens, Critical Path Institute, Tucson, Arizona.
  • Migliori GB; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.
  • Fletcher HA; Department of Immunology and Infection, London School of Hygiene and Tropical Medicine.
  • McNerney R; TB Alert, Brighton, United Kingdom.
  • Centis R; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.
  • D'Ambrosio L; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.
  • Bates M; University of Zambia-University College London Medical School Research and Training Project, University Teaching Hospital, Lusaka, Zambia.
  • Kibiki G; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
  • Kapata N; University of Zambia-University College London Medical School Research and Training Project, University Teaching Hospital, Lusaka, Zambia.
  • Corrah T; Department of Infectious Diseases and Tropical Medicine, Northwick Park Hospital.
  • Bomanji J; Department of Nuclear Imaging, University College London Hospitals NHS Foundation Trust, United Kingdom.
  • Vilaplana C; Unitat de Tuberculosi Experimental, Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Ctra. de Can Ruti, Camí de les Escoles, Barcelona, Spain.
  • Johnson D; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Mwaba P; University of Zambia-University College London Medical School Research and Training Project, University Teaching Hospital, Lusaka, Zambia.
  • Maeurer M; Therapeutic Immunology, Departments of Laboratory Medicine and Microbiology, Tumour and Cell Biology, Karolinska Institute, Stockholm, Sweden.
  • Zumla A; Division of Infection and Immunity, University College London and National Institute for Health Research Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, United Kingdom.
Clin Infect Dis ; 61Suppl 3: S102-18, 2015 Oct 15.
Article em En | MEDLINE | ID: mdl-26409271
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Vacinas contra a Tuberculose / Antituberculosos Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Vacinas contra a Tuberculose / Antituberculosos Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article